Ginkgo Bioworks Holdings, Inc. shares fall 1.60% in premarket as overall U.S. stock market rises.

martes, 1 de julio de 2025, 4:10 am ET1 min de lectura
Ginkgo Bioworks Holdings, Inc. surged 19.20% in premarket trading, driven by a broader market rally with the Dow Jones Industrial Average rising over 100 points. The company specializes in a cell programming platform, offering end-to-end cell engineering and biosafety services across pharmaceuticals, agriculture, and industrial sectors, supporting high-demand markets such as drug development and antibody research.

Ginkgo Bioworks Holdings, Inc. shares fall 1.60% in premarket as overall U.S. stock market rises.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios